ECSP034704A - INHIBITOR COMBINATIONS (ES) OF THE STEROL ABSORPTION WITH BLOOD MIDIFIER (ES) TO TREAT VASCULAR TABLES - Google Patents

INHIBITOR COMBINATIONS (ES) OF THE STEROL ABSORPTION WITH BLOOD MIDIFIER (ES) TO TREAT VASCULAR TABLES

Info

Publication number
ECSP034704A
ECSP034704A ECSP034704A ECSP034704A EC SP034704 A ECSP034704 A EC SP034704A EC SP034704 A ECSP034704 A EC SP034704A EC SP034704 A ECSP034704 A EC SP034704A
Authority
EC
Ecuador
Prior art keywords
blood
midifier
tables
sterol absorption
treat vascular
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Teddy Kosoglou
Rudyard Joseph Ress
John Strony
Enrico P Veltri
William Hauer
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34572580&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP034704(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of ECSP034704A publication Critical patent/ECSP034704A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona composiciones, combinaciones y métodos que incluyen: a) al menos un inhibidor de la absorción de esterol; y b) al menos un modificador sanguíneo, el cual puede ser útil para tratar cuadros vasculares y para reducir los niveles plasmáticos de esteroles.The present invention provides compositions, combinations and methods that include: a) at least one sterol absorption inhibitor; and b) at least one blood modifier, which may be useful for treating vascular conditions and for reducing sterile plasma levels.

ECSP034704 2001-01-26 2003-07-24 INHIBITOR COMBINATIONS (ES) OF THE STEROL ABSORPTION WITH BLOOD MIDIFIER (ES) TO TREAT VASCULAR TABLES ECSP034704A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26439601P 2001-01-26 2001-01-26

Publications (1)

Publication Number Publication Date
ECSP034704A true ECSP034704A (en) 2003-09-24

Family

ID=34572580

Family Applications (3)

Application Number Title Priority Date Filing Date
ECSP034704 ECSP034704A (en) 2001-01-26 2003-07-24 INHIBITOR COMBINATIONS (ES) OF THE STEROL ABSORPTION WITH BLOOD MIDIFIER (ES) TO TREAT VASCULAR TABLES
ECSP034702 ECSP034702A (en) 2001-01-26 2003-07-24 COMBINATIONS DEACTIVATOR (S) OF THE RECEIVER OF PEROXISMAL PROLIFERATION ACTIVATION (PPAR) AND INHIBITOR (ES) OF STEROL ABSORPTION AND TREATMENT FOR VASCULAR INDICATIONS
ECSP034703 ECSP034703A (en) 2001-01-26 2003-07-24 COMBINATIONS OF STEROL ABSORPTION INHIBITOR (S) WITH CARDIOVASCULAR AGENT (S) FOR THE TREATMENT OF VASCULAR CONDITIONS

Family Applications After (2)

Application Number Title Priority Date Filing Date
ECSP034702 ECSP034702A (en) 2001-01-26 2003-07-24 COMBINATIONS DEACTIVATOR (S) OF THE RECEIVER OF PEROXISMAL PROLIFERATION ACTIVATION (PPAR) AND INHIBITOR (ES) OF STEROL ABSORPTION AND TREATMENT FOR VASCULAR INDICATIONS
ECSP034703 ECSP034703A (en) 2001-01-26 2003-07-24 COMBINATIONS OF STEROL ABSORPTION INHIBITOR (S) WITH CARDIOVASCULAR AGENT (S) FOR THE TREATMENT OF VASCULAR CONDITIONS

Country Status (3)

Country Link
CN (2) CN101297969B (en)
EC (3) ECSP034704A (en)
ZA (2) ZA200305692B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103086938A (en) * 2011-10-28 2013-05-08 沈阳药科大学 Ezetimibe synthesis method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3300B (en) * 1992-12-23 1995-06-26 Schering Corp Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
EP0766667A1 (en) * 1994-06-20 1997-04-09 Schering Corporation Substituted azetidinone compounds useful as hypocholesterolemic agents
AU779264B2 (en) * 1998-12-23 2005-01-13 G.D. Searle Llc Combinations for cardiovascular indications

Also Published As

Publication number Publication date
ZA200305694B (en) 2004-10-25
ECSP034702A (en) 2003-09-24
CN1915429A (en) 2007-02-21
CN1915429B (en) 2010-12-15
CN101297969B (en) 2011-03-09
ZA200305692B (en) 2004-10-25
CN101297969A (en) 2008-11-05
ECSP034703A (en) 2003-09-24

Similar Documents

Publication Publication Date Title
ECSP074704A (en) INHIBITOR COMBINATIONS (S) OF STEROL ABSORPTION WITH BLOOD MODIFIER (S) TO TREAT VASCULAR TABLES
AR032403A1 (en) INHIBITOR COMBINATIONS (ES) OF STEROL ABSORPTION WITH BLOOD MODIFIER (ES) TO TREAT VASCULAR TABLES
ECSP11004702A (en) COMBINATIONS DEACTIVATOR (S) OF THE PEROXISMAL PROLIFERATION ACTIVATION RECEIVER (PPAR) AND STEROL ABSORPTION INHIBITOR (ES) AND TREATMENTS FOR VASCULAR INDICATIONS
NO20041598L (en) Methods for the treatment or prophylaxis of vascular inflammation using sterol absorption inhibitor (s)
DK1429756T3 (en) Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
BRPI0518565A2 (en) cardiovascular compositions
MXPA03006631A (en) Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications.
CY1106149T1 (en) THE USE OF SUBSTITUTED AZETIDINONE COMPOUNDS FOR THE TREATMENT OF SITOSTEPOLEMIA
EP2332527A3 (en) Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
UY28041A1 (en) LOW DOSE METHODS FOR THE TREATMENT OF DISORDERS IN WHICH TNFA'S ACTIVITY IS HARMFUL.
EA200601648A1 (en) GLUCOSAMINE AND GENERAL PROCEDURES GLUCOSAMINE / ANTI-INFLAMMATORY AGENT, COMPOSITIONS AND METHODS
WO2004043456A8 (en) Cholesterol absorption inhibitors for the treatment of demyelination
WO2005046797A3 (en) Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
EA200800755A1 (en) IKK INHIBITORS INTRODUCED FOR THE TREATMENT OF ENDOMETRIOSIS
MX2022013081A (en) COMPOUNDS FOR THE TREATMENT OF SARS.
BRPI0508254A (en) methods and compositions for treating or preventing psychiatric disorders with cox-2 inhibitors alone and in combination with antidepressant agents
BR0209327A (en) Composition for treatment of drug-induced constipation
UY39863A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS-RELATED DISEASES
EA200401210A1 (en) ANDROGENIC PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION
BR0213317A (en) Use of a compound, method of treating a gastrin-related disorder, pharmaceutical composition, kit, uses of a composition, and a proton pump inhibitor, methods of preparing a pharmaceutical composition and a compound, and, compound
ECSP034704A (en) INHIBITOR COMBINATIONS (ES) OF THE STEROL ABSORPTION WITH BLOOD MIDIFIER (ES) TO TREAT VASCULAR TABLES
ECSP066685A (en) COMPOSITION THAT INCLUDES A WATER EXTRACT OF RED VINE LEAVES AND AN AGENT THAT IMPROVES THE BLOOD CIRCULATION FOR THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCIES
UY26648A1 (en) VASOPEPTIDASE INHIBITORS TO TREAT ISOLATED SYSTOLIC HYPERTENSION
BRPI0507302A (en) Method and Compositions for the Treatment of Lipodystrophy
EP1859796A3 (en) Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors